MORGAN STANLEY - 28 Feb 2025 SCHEDULE 13G/A Report for Sage Therapeutics, Inc. Common Stock (SAGE)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: Sage Therapeutics, Inc. Common Stock
Symbol: SAGE
Shares outstanding: 63.3M shares
Disclosed Ownership: 1.01M shares
Ownership: 1.6%
Form type: SCHEDULE 13G/A
Filing time: 06 Mar 2025, 16:28:17 UTC
Date of event: 28 Feb 2025
Previous filing: 05 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	1.6%	1.01M	0	922K	Christopher O'Hara	Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC	0.3%	173K	0	173K	Christopher O'Hara	Authorized Signatory, Morgan Stanley & Co. LLC